Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 12
Submit an article Journal homepage
313
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement

Fateeha Furqana Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Grace Watsona Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Felipe Samaniegoa Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Luis E. Fayada Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Rashmi Kanagal-Shamannab Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0001-7829-5249View further author information
ORCID Icon,
Michael W. Morrisona Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Philip A. Thompsonc Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Raphael E. Steinera Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0003-3717-3629View further author information
ORCID Icon,
Linda Chid Department of Neuro-Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Bouthaina Dabajae Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Chelsea C. Pinnixe Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0003-3982-3664View further author information
ORCID Icon,
Sattva S. Neelapua Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Loretta J. Nastoupila Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Paolo Stratia Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
 show all
Pages 2980-2984 | Received 17 Apr 2020, Accepted 27 Jun 2020, Published online: 10 Jul 2020

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chiara Cavalloni, Marzia Varettoni, Sara Rattotti & Luca Arcaini. (2021) Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma. Expert Opinion on Pharmacotherapy 22:13, pages 1643-1649.
Read now

Articles from other publishers (2)

Elena Flospergher, Fabrizio Marino, Teresa Calimeri, Maria Giulia Cangi, Andrés José María Ferreri, Maurilio Ponzoni & Lucia Bongiovanni. (2023) Primary central nervous system marginal zone lymphoma. British Journal of Haematology.
Crossref
Emanuele Cencini, Alberto Fabbri, Donatella Raspadori, Alessandro Gozzetti & Monica Bocchia. (2021) Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders?. BLOOD RESEARCH 56:4, pages 333-334.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.